The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President, Global Medical Affairs, and the search was successfully completed in less than 60 days with the appointment of Dr. Christophe Hotermans. A seasoned medical affairs executive and industry veteran, Dr. Hotermans will lead the execution and development of worldwide medical strategies, activities, and operations as a member of the Akcea executive management team. Dr. Hotermans has 20+ years of experience, including more than 12 years in the biotechnology industry with roles in drug safety and medical affairs, both US and global. During this time, he launched five products across multiple therapeutic areas in specialty care and rare disease. His expertise in developing global medical strategies in these areas will be a great asset to Akcea as they continue to globally execute two commercial launches. The Chase Group appreciates a relational collaboration with the Akcea executive team and looks forward to the continued partnership as Akcea Therapeutics develops and commercializes products for patients living with serious and rare diseases.
To learn how The Chase Group can identify high caliber talent for your team, please contact karen@chasegroup.com.
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President, Global Medical Affairs, and the search was successfully completed in less than 60 days with the appointment of Dr. Christophe Hotermans. A seasoned medical affairs executive and industry veteran, Dr. Hotermans will lead the execution and development of worldwide medical strategies, activities, and operations as a member of the Akcea executive management team. Dr. Hotermans has 20+ years of experience, including more than 12 years in the biotechnology industry with roles in drug safety and medical affairs, both US and global. During this time, he launched five products across multiple therapeutic areas in specialty care and rare disease. His expertise in developing global medical strategies in these areas will be a great asset to Akcea as they continue to globally execute two commercial launches. The Chase Group appreciates a relational collaboration with the Akcea executive team and looks forward to the continued partnership as Akcea Therapeutics develops and commercializes products for patients living with serious and rare diseases.
To learn how The Chase Group can identify high caliber talent for your team, please contact karen@chasegroup.com.
The Chase Group Secures VP, Head of Regulatory Affairs for Checkmate Pharmaceuticals
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate…
The Chase Group Secures Teng Jin Ong for Genmab
Amid an era of rapid growth, Genmab retained The Chase Group to secure a new clinical development medical executive as they work to pioneer the…
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained…
Leadership Team Grows at Biologics Consulting Through Partnership with The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…-
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….